Skip to main content

Table 2 Pulmonary function test, 6-min walking test, and CT scan at 1-year follow-up

From: Clinical status of patients 1 year after hospital discharge following recovery from COVID-19: a prospective cohort study

Variables

All patients

Non-severe patients

Severe patients

P value *

Pulmonary function, N

113

87

26

 

FVC < 80% predicted, N (%)

4 (3.5)

2 (2.3)

2 (7.7)

0.483

FEV1 < 80% predicted, N (%)

9 (8.0)

7 (8.0)

2 (7.7)

1.000

FVC/FEV1 < 80% predicted, N (%)

0 (0.0)

0 (0.0)

0 (0.0)

na

MMEF < 65% predicted, N (%)

36 (31.9)

27 (31.0)

9 (34.6)

0.917

DLCO < 80%, predicted, N (%)

40 (35.4)

27 (31.0)

13 (50.0)

0.123

DLCO/VA < 80%, predicted, N (%)

10 (8.8)

5 (5.7)

5 (19.2)

0.084

TLC < 80%, predicted, N (%)

9 (8.0)

5 (5.7)

4 (15.4)

0.238

RV < 80% predicted, N (%)

2 (1.8)

2 (2.3)

0 (0.0)

1.000

6-min walking test, N

187

146

41

 

Distance < 450 m, N (%)

86 (46.0)

61 (41.8)

25 (61.0)

0.045

CT scan, N

208

160

48

 

Involvement of the lesions, N (%)

   

 < 0.001

No involvement

76 (36.5)

69 (43.1)

7 (14.6)

 

Single lobe

56 (26.9)

48 (30.0)

8 (16.7)

 

Bilateral multilobe

76 (36.5)

43 (26.9)

33 (68.8)

 

No. of lobes involved, median (IQR)

1 (0 − 2)

1 (0 − 2)

2 (1 − 4)

 < 0.001

Total CT score, mean (SD)

2.29 (3.29)

1.44 (2.05)

5.15 (4.78)

 < 0.001

  1. *P values were calculated with student t test, or Wilcoxon rank sum test, or Chi-squared test
  2. FVC forced vital capacity; FEV1 forced expiratory volume in 1 s; MMEF, maximal mid-expiratory flow; DLCO, diffusing capacity of the lung for carbon monoxide; DLCO/VA, DLCO corrected for alveolar volume; TLC total lung capacity; RV residual volume; na not available